Fox Run Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-47,643
Closed -$777K 1249
2025
Q4
$777K Buy
47,643
+21,410
+82% +$323K 0.12% 313
2025
Q3
$307K Buy
+26,233
New +$342K 0.05% 674
2025
Q2
Sell
-30,978
Closed -$270K 1247
2025
Q1
$270K Buy
+30,978
New +$391K 0.04% 703
2024
Q4
Sell
-35,849
Closed -$809K 1185
2024
Q3
$809K Buy
+35,849
New +$741K 0.18% 191
2024
Q2
Sell
-12,255
Closed -$460K 1091
2024
Q1
$460K Buy
+12,255
New +$538K 0.1% 397
2023
Q4
Sell
-24,736
Closed -$1.02M 1029
2023
Q3
$1.02M Buy
24,736
+11,105
+81% +$578K 0.3% 66
2023
Q2
$761K Buy
+13,631
New +$738K 0.21% 157
2021
Q1
Sell
-2,703
Closed -$383K 318
2020
Q4
$383K Buy
+2,703
New +$392K 0.77% 21

Other funds holding TXG